FIELD: medicine.
SUBSTANCE: invention refers to a vaccine containing a combination of non-living antigens of Lawsonia intracellularis, Mycoplasma hyopneumoniae and porcine circovirus, and a pharmaceutically acceptable carrier. The invention also refers to a kit comprising a first container with the non-living antigens of Lawsonia intracellularis, one or more other containers with the antigens of Mycoplasma hyopneumoniae and porcine circovirus, and an instruction for mixing the antigens of Lawsonia intracellularis, Mycoplasma hyopneumoniae and porcine circovirus for preparing one combined vaccine for systemic vaccination.
EFFECT: group of inventions provides the more effective prevention of the diseases caused by these pathogens.
8 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINE AGAINST LAWSONIA INTRACELLULARIS | 2009 |
|
RU2523561C2 |
VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
AQUEOUS COMPOSITION CONTAINING BIOLOGICAL ANTIGEN AND ACRYLIC ACID POLYMER | 2012 |
|
RU2565443C2 |
COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
MUTANT MYCOPLASMA HYOPNEUMONIAE STRAINS | 2013 |
|
RU2689671C2 |
Mycoplasma hyopneumoniae AVIRULENT ADJUVANT LIVE VACCINE | 2008 |
|
RU2489164C9 |
INTRADERMAL VACCINE AGAINST PCV2 AND PRRS VIRUS INFECTION | 2017 |
|
RU2746127C2 |
Authors
Dates
2013-10-27—Published
2009-04-16—Filed